Cargando…
What are the Unmet Needs and Most Relevant Treatment Outcomes According to Patients with Inflammatory Bowel Disease? A Qualitative Patient Preference Study
BACKGROUND AND AIMS: As more therapeutic options with their own characteristics become available for inflammatory bowel disease [IBD], drug development and individual treatment decision-making needs to be tailored towards patients’ preferences and needs. This study aimed to understand patient prefer...
Autores principales: | Schoefs, Elise, Vermeire, Séverine, Ferrante, Marc, Sabino, João, Lambrechts, Tessy, Avedano, Luisa, Haaf, Isabella, De Rocchis, Maria Stella, Broggi, Andrea, Sajak-Szczerba, Magdalena, Saldaña, Roberto, Janssens, Rosanne, Huys, Isabelle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10069611/ https://www.ncbi.nlm.nih.gov/pubmed/36165579 http://dx.doi.org/10.1093/ecco-jcc/jjac145 |
Ejemplares similares
-
Indirect Costs of Inflammatory Bowel Diseases: A Comparison of Patient-Reported Outcomes Across 12 European Countries
por: Holko, Przemysław, et al.
Publicado: (2022) -
Out-of-pocket expenses of patients with inflammatory bowel disease: a comparison of patient-reported outcomes across 12 European countries
por: Holko, Przemysław, et al.
Publicado: (2022) -
What matters most to patients with multiple myeloma? A Pan-European patient preference study
por: Janssens, Rosanne, et al.
Publicado: (2022) -
New biologics and small molecules in inflammatory bowel disease: an
update
por: Sabino, João, et al.
Publicado: (2019) -
Opportunities and Challenges of Web-Based and Remotely Administered Surveys for Patient Preference Studies in a Vulnerable Population
por: Oliveri, Serena, et al.
Publicado: (2021)